Brokers rate these 2 top ASX shares as buys in June 2022

These two ASX shares could be top ideas, according to brokers.

| More on:
a young boy dressed up in a business suit and tie has a cute grin and holds two fingers up.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Experts have named the two ASX shares below as leading picks
  • Mach7 is a medical imaging systems business
  • BWX is a natural beauty business with global aspirations

Brokers have named a number of ASX shares as opportunities in June 2022. Businesses that are growing revenue at a relatively fast pace could turn into much bigger businesses over time.

These are businesses that are thought of as longer-term opportunities because of their current valuations and their prospects of growth.

Brokers try to calculate where a company’s share price is going to be in 12 months after their analyses of the business. That’s called a price target. Price targets aren’t guarantees, but just a guess and acknowledgement of how much potential growth the broker sees for the business. The bigger the price target, the more possible gains the broker thinks there is.

Let’s look at two of the ASX share opportunities.

Mach7 Technologies Ltd (ASX: M7T)

Mach7 is a business that provides medical imaging systems that develops “innovative image management and viewing solutions for healthcare organisations”.

It has more than 150 customers across 15 countries including integrated delivery networks, national health systems, medical research facilities, large academic medical institutions, regional community hospitals, private radiology practices, and independent provider groups.

Morgans currently rates it as a buy with a price target of $1.55. That implies a potential rise of more than 150% over the next year.

The broker took into account the ASX share’s recent FY22 third quarter.

In that update, the business said it achieved net positive operating cashflows for the quarter of $0.5 million. It also generated record financial year to date earnings before interest, tax, depreciation and amortisation (EBITDA) of $3.2 million, up $4.7 million or 306% on last year. Third-quarter sales orders rose $4.4 million to $26.5 million. It’s also on track to deliver sales orders of $30 million for FY22.

The company also pointed to two new channel partnerships – AdvaHealth and Althea. On Althea, Mach7 said that it has a presence in 17 countries and will initially be working in Italy and the UK. There is also potential for further expansion in the EU.

BWX Limited (ASX: BWX)

BWX is a natural beauty business that has a number of brands including Sukin, Andalou Naturals, Mineral Fusion, and Go-To Skincare. The ASX share also sells products through the e-commerce sites Flora & Fauna and Nourished Life. It’s looking to expand the brands to more countries.

The broker UBS currently rates BWX as a buy with a price target of $2.55. That implies a possible rise in the BWX share price of more than 80% over the next year.

BWX recently gave a market presentation that looked at various elements of the business.

The company has done a business-wide review of financial and operating performance, as well as ongoing initiatives to support a sustainable cost base. It has identified $5 million in extra costs it can cut to streamline its operating model. In particular, it’s looking to improve its marketing return on investment (ROI) and achieve trade spend efficiency improvements.

As well, BWX is looking to grow its profit margins through various initiatives including price increases, increased manufacturing capacity, and improved operational efficiency.

The company is expecting to grow its revenue by between 20% to 25% in FY22 while the mid-point of the underlying EBITDA guidance could mean growth of around 3%.

Using UBS’ estimates on the ASX share, the BWX share price is valued at 17 times FY22’s estimated earnings and 11 times FY23’s estimated earnings.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended MACH7 FPO. The Motley Fool Australia has recommended BWX Limited and MACH7 FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

a man in a business shirt, tie and suit holds a mobile phone to his ear while he drinks a large glass of milk.
Share Market News

A2 Milk share price on watch amid FDA update

Here's what the FDA said...

Read more »

A man in a suit smiles at the yellow piggy bank he holds in his hand.
Share Market News

Is the NAB share price a buy following the bank’s latest update?

Are NAB's shares in the buy zone after its update?

Read more »

Business woman watching stocks and trends while thinking
Share Market News

5 things to watch on the ASX 200 on Wednesday

Another big day is expected for the ASX 200 on Wednesday...

Read more »

A woman lies back and relaxes in her boat with a big smile on her face as it floats on the rising tide.
Share Market News

Why the Charter Hall Long WALE REIT share price isn’t rocking the boat

It's steady as she goes for this ASX real estate investment trust.

Read more »

A man and a woman sit in front of a laptop looking fascinated and captivated.
Share Market News

Here are the top 10 ASX 200 shares today

Tuesday was a particularly good day for these 10 ASX 200 shares.

Read more »

A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin.

Can the Bitcoin price reach US$30,000 again in 2022?

Rising interest rates have resulted in significantly less institutional investor interest in cryptos.

Read more »

An office worker and his desk covered in yellow post-it notes
Share Market News

Here are the 3 most heavily traded ASX 200 shares on Tuesday

Once again, its ASX 200 lithium stocks that are dominating today;s volume charts.

Read more »

A woman shouts through a megaphone.
Share Market News

In this most volatile of years, the ASX 200 is within shouting distance of turning positive

ASX 200 continues its recovery, now within shouting distance of turning positive for 2022.

Read more »